What is the translation of " DOZA INZULINA " in English?

• insulin dose

Examples of using Doza inzulina in Croatian and their translations into English

Srednja dnevna doza inzulina(IU)1.
Mean daily insulin dose(IU)1.

Doza inzulina(IU/dan) u 52. tjednu2.
Insulin dose(IU/day) at week 522.

Pogrešno proračunata doza inzulina.
Accidentally miscalculating an insulin dose.

Doza inzulina(IU/dan) u 52. tjednub, 3.
Insulin dose(IU/day) at week 52b, 3.

Ako bolesnici prijave hipoglikemiju, doza inzulina mora se sniziti.
If patients report hypoglycaemia, the dose of insulin should be decreased.

Srednja dnevna doza inzulina(IU)1 Početna vrijednost srednja.
Mean daily insulin dose(IU)1.

Neki lijekovi utječu na razinu šećera u krvi, a to znači da će se doza inzulina možda morati promijeniti.
Some medicines affect your blood sugar level, and this may mean that your insulin dose has to change.

Hipoglikemija može nastupiti ako je doza inzulina prevelika u odnosu na potrebe za inzulinom vidjeti dijelove 4.5, 4.8 i 4.9.
Hypoglycaemia may occur if the insulin dose is too high in relation to the insulin requirement see sections 4.5, 4.8 and 4.9.

Među bolesnicima koji su uzimali metformin, početna vrijednost HbA1c bila je 8,70%, a početna doza inzulina 37 IU/dan.
Among patients taking metformin, baseline HbA1c was 8.70% and baseline insulin dose was 37 IU/day.

Bolesnicima čiji je HbA1c iznosio ≤ 8,0% na početku ispitivanja, doza inzulina smanjena je za 20% kako bi se umanjio rizik od hipoglikemije.
The insulin dose was reduced by 20% for patients with baseline HbA1c≤8.0% in order to minimise the risk of hypoglycaemia.

Doza inzulina koju je primao s vremenom je postajala sve manja i konačno, zahvaljujući promjeni prehrane, više nije trebao inzulinske injekcije.
Insulin doses which he was receiving became lesser in time, and finally, thanks to the change of diet, he no longer needed insulin injections.

U skupini liječenoj degludek inzulinom+liraglutidom doza inzulina smanjena je za 20% kako bi se smanjio rizik od hipoglikemije.
In the insulin degludec+ liraglutide arm, the insulin dose was reduced by 20% in order to minimize the risk of hypoglycaemia.

U 48. i 104. tjednu, doza inzulina je ostala stabilna u usporedbi s početnom vrijednošću od kod ispitanika liječenih dapagliflozinom 10 mg prosječna doza 76 IU/dan.
At Weeks 48 and 104, the insulin dose remained stable compared to baseline in subjects treated with dapagliflozin 10 mg at an average dose of 76 IU/day.

U skupini koja je uzimala degludek inzulin+ liraglutid, doza inzulina smanjena je za 20% kako bi se smanjio rizik od hipoglikemije.
In the insulin degludec+ liraglutide arm, the insulin dose was reduced by 20% in order to minimise the risk of hypoglycaemia.

U tjednu 48 i 104 doza inzulina ostala je stabilna u odnosu na početnu dozu u ispitanika liječenih dapagliflozinom od 10 mg, u prosječnoj dozi od 76 IU na dan.
At Weeks 48 and 104, the insulin dose remained stable compared to baseline in subjects treated with dapagliflozin 10 mg at an average dose of 76 IU/day.

Hipoglikemija, najčešća nuspojava liječenja inzulinom, može nastupiti ako je doza inzulina previsoka u odnosu na potrebu za inzulinom.
Hypoglycaemia, the most frequent adverse reaction of insulin therapy, may occur if the insulin dose is too high in relation to the insulin requirement.

Tijekom početnih 18 tjedana doza inzulina je bila stabilna, ali se prilagođavala u cilju postizanja razine glukoze natašte(FPG)< 110 mg/dl u slijedećih 60 tjedana.
During the initial 18 weeks the insulin dose was kept stable, but was adjusted to achieve a FPG< 110 mg/dl in the following 60 weeks.

Hipoglikemija(vrlo često), koja je općenito najčešća nuspojava inzulinske terapije, može nastupiti ako je doza inzulina previsoka u odnosu na potrebu za inzulinom vidjeti dio 4.4.
Hypoglycaemia(very common), in general the most frequent adverse reaction of insulin therapy, may occur if the insulin dose is too high in relation to the insulin requirement see section 4.4.

Tijekom početnih 18 tjedana i posljednjih 12 tjedana doza inzulina je bila stalna, ali se između 19. i 40. tjedna prilagođavala u cilju postizanja razine glukoze< 100 mg/dl[5, 5 mmol/l] preprandijalno i razine glukoze< 140 mg/dl[7, 8 mmol/l] postprandijalno.
During the initial 18 weeks and the last 12 weeks, the insulin dose was kept stable, but was adjusted to achieve pre-prandial glucose levels< 100 mg/dl[5.5 mmol/l], and post-prandial glucose levels< 140 mg/dl[7.8 mmol/l] between Weeks 19 and 40.

Nuspojave Sažetak sigurnosnog profila Hipoglikemija, koja je općenito najčešća nuspojava inzulinske terapije, može nastupiti ako je doza inzulina previsoka u odnosu na potrebu za inzulinom.
Undesirable effects Summary of safety profile Hypoglycaemia, in general the most frequent adverse reaction of insulin therapy, may occur if the insulin dose is too high in relation to the insulin requirement.

Na ovaj proces utječe nekoliko faktora primjerice, doza inzulina, put i mjesto injiciranja, debljina potkožnog masnog tkiva, tip šećerne bolesti.
This process is influenced by several factors e.g. insulin dose, injection route and site, thickness of subcutaneous fat, type of diabetes.

CHMP je zabilježio da formulacije veće jačine lijeka Tresiba ispunjavaju medicinsku potrebu bolesnika kojima je potrebna viša doza inzulina(poput pretilih bolesnika), čime bi se tim bolesnicima omogućilo uzimanje dnevne doze u jednoj injekciji umjesto u dvije.
The CHMP noted that the higher strength formulation of Tresiba met a medical need for patients requiring higher dose insulin(such as overweight patients), which would allow these patients to take their daily dose in a single injection rather than two injections.

U skupini koja je primala eksenatid s trenutnim oslobađanjem doza inzulina povećana se za 13 jedinica na dan u usporedbi s 20 jedinica na dan u skupini koja je primala placebo.
In the immediate-release exenatide arm the insulin dose increased by 13 units/day compared to 20 units/day on the placebo arm.

Ovaj učinak liječenja usporediv je s onim inzulina glargina u 26-tjednom ispitivanju(prosječna doza inzulina 24, 9 IU/dan, raspon 4-95 IU/dan, na kraju ispitivanja) odnosno s učinkom aspart inzulina u 52-tjednom ispitivanju prosječna doza inzulina 24, 4 IU/dan, raspon 3-78 IU/dan, na kraju ispitivanja.
This treatment effect was comparable to that of insulin glargine in a 26-week study(mean insulin dose 24.9 IU/day, range 4-95 IU/day, at the end of study) and biphasic insulin aspart in a 52-week study mean insulin dose 24.4 IU/day, range 3-78 IU/day, at the end of study.

Možda će biti potrebno promijeniti Vašu dozu inzulina tijekom trudnoće i nakon poroda.
Your insulin dose may need to be changed during pregnancy and after delivery.

Nađi potvrdu da su svi primali doze inzulina.
Confirm they all had the insulin dose.

Ako se liječite inzulinom, Vaš liječnik će možda morati prilagoditi Vašu dozu inzulina.
If you are treated with insulin, your doctor may need to adjust your insulin dose.

Ispitanici sa smanjenjem srednje dnevne doze inzulina od najmanje 10.
Subjects with mean daily insulin dose reduction of at least 10.

Ne smijete se služiti tim brojevima za odmjeravanje doze inzulina.
These numbers should not be used for measuring an insulin dose.

Time ćete osigurati da dobijete punu dozu inzulina.
This helps you to ensure that you get your full insulin dose.